Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2017

View Archived Issues

New S1P1-specific PET radioligands for imaging neuroinflammation show promise

Sunovion files IND for second compound from drug discovery collaboration with PsychoGenics

OSE Immunotherapeutics collaborates with Memorial Sloan Kettering on OSE-703

Carma Therapeutics closes initial financing

DSMB recommends continuation of NASH-CX trial of GR-MD-02

FDA awards fast track designation to tanezumab for chronic pain indications

AbbVie and Principia Biopharma establish oral immunoproteasome inhibitor collaboration

[18F]FC-0324, a new PET tracer targeting cannabinoid CB2 receptors

Zafgen details results from first-in-human trial of obesity candidate ZGN-1061

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents ALK inhibitors

Moleculin Biotech starts IND preparation for WP-1220 for CTCL

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

AbbVie discovers 5-HT2C receptor agonists

Pulmatrix in-licenses RespiVert kinase inhibitors

Ohara Pharmaceutical discloses prodrugs of azacytidine and decitabine

Genentech and Xenon Pharmaceuticals disclose Nav1.7 channel blockers

Grant supports BrainStorm Cell Therapeutics' development of NurOwn

Galapagos compound GLPG-1690 given U.S. orphan designation for idiopathic pulmonary fibrosis

NCI grant supports continued research at Case Western on Barrett's esophagus

[18F]GE-180 evaluated in patients with high grade glioma and multiple sclerosis

AbbVie drug receives FDA orphan status for onchocerciasis and lymphatic filariasis

IT-139 named a U.S. orphan drug for pancreatic cancer

FDA grants breakthrough therapy designation for OMS-721 in IgA nephropathy

Phase III trial of Bronchitol in cystic fibrosis meets primary endpoint

Cellth Systems granted rights to CTC cell-tethering technology

Repurposed cancer drug SU-9516 may have potential for Duchenne muscular dystrophy

FDA issues 510(k) clearance for Techlab's E. Histolytica Quik Chek test

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...